Alternatives to Fight Vancomycin-Resistant <i>Staphylococci</i> and <i>Enterococci</i>
Gram positive pathogens are a significant cause of healthcare-associated infections, with <i>Staphylococci</i> and <i>Enterococci</i> being the most prevalent ones. Vancomycin, a last resort glycopeptide, is used to fight these bacteria but the emergence of resistance against...
Main Authors: | Benjamin Baëtz, Abdelhakim Boudrioua, Axel Hartke, Caroline Giraud |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/10/9/1116 |
Similar Items
-
Prevention and Killing Efficacy of Carbapenem Resistant <i>Enterobacteriaceae</i> (CRE) and Vancomycin Resistant <i>Enterococci</i> (VRE) Biofilms by Antibiotic-Loaded Calcium Sulfate Beads
by: Paul Stoodley, et al.
Published: (2020-07-01) -
Peptide/β-Peptoid Hybrids with Activity against Vancomycin-Resistant Enterococci: Influence of Hydrophobicity and Structural Features on Antibacterial and Hemolytic Properties
by: Martin Vestergaard, et al.
Published: (2021-05-01) -
Advances and Prospects in Vaccine Development against Enterococci
by: Ermioni Kalfopoulou, et al.
Published: (2020-11-01) -
Antimicrobial Peptides with Antibacterial Activity against Vancomycin-Resistant <i>Staphylococcus aureus</i> Strains: Classification, Structures, and Mechanisms of Action
by: Isabella Hernández-Aristizábal, et al.
Published: (2021-07-01) -
Nosocomial Infection with Vancomycin-dependent Enterococci
by: Paul A. Tambyah, et al.
Published: (2004-07-01)